Médecine et maladies infectieuses
The most recent articles from:
Med Mal Infect
-
COVID-19 is a new infectious disease, for which there is currently no treatment. It is therefore necessary to explore biomarkers to determine the extent of lung lesions and disease severity. ⋯ In the early stage of COVID-19 CRP levels were positively correlated with lung lesions and could reflect disease severity.
-
Letter Meta Analysis
Interleukin-6 as a potential biomarker of COVID-19 progression.
-
Letter Case Reports
Borrelia crocidurae tick-borne relapsing fever upon return from Senegal.